Cargando…
Diabetes and the risk of cirrhosis and HCC: An analysis of the UK Biobank
BACKGROUND: Diabetes increases the risk of cirrhosis and HCC. We aimed to assess such associations given different diabetes statuses. METHODS: We included 449,497 participants in the UK Biobank cohort (mean age 56.7±8.0 y; 45.5% male) and assessed the association between preclinical diabetes (predia...
Autores principales: | Ye, Fangzhou, Chen, Liangkai, Zheng, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586863/ https://www.ncbi.nlm.nih.gov/pubmed/37851413 http://dx.doi.org/10.1097/HC9.0000000000000280 |
Ejemplares similares
-
HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023) -
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022) -
Plant-based dietary patterns, genetic predisposition and risk of colorectal cancer: a prospective study from the UK Biobank
por: Liu, Fubin, et al.
Publicado: (2023) -
Diet and Risk of Non-Alcoholic Fatty Liver Disease, Cirrhosis, and Liver Cancer: A Large Prospective Cohort Study in UK Biobank
por: Guo, Wen, et al.
Publicado: (2022) -
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials
por: Kraglund, Frederik, et al.
Publicado: (2023)